Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alanyl-glutamine plus omega-3 fish oil parenteral nutrition in postoperative gastroduodenal perforation
ChiCTR2600122119Phase 4Not yet recruiting
- Sponsor
- Yongchuan Hospital Affiliated to Chongqing Medical University
- Start
- Apr 2026
- Modality
- Small Molecules, Peptides, Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, randomised trial of alanyl glutamine and omega-3-acid triglycerides in Gastroduodenal ulcer perforation (GUP) (3 arms), sponsored by Yongchuan Hospital Affiliated to Chongqing Medical University. Primary endpoints: Serum albumin, Total protein and 6 more. Planned start Apr 2026; status: not yet recruiting.
02
Drugs
alanyl glutamineomega-3-acid triglycerides
03
Conditions
Gastroduodenal ulcer perforation (GUP)
Beyond the preview
Go deeper on ChiCTR2600122119.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600122119.